Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2021 pubmed 10 citations

Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model.

Gürsoy. Ulvi K UK; Salli. Krista K; Söderling. Eva E; Gürsoy. Mervi M; Hirvonen. Johanna J; Ouwehand. Arthur C AC

Key Findings

  • 3‑fucosyllactose (3‑FL) alone or with 2′‑fucosyllactose (2′‑FL) raised hBD‑2 protein after 24 h at 1% concentration
  • No change in hBD‑3, LL‑37 (cathelicidin) or pro‑inflammatory cytokines was observed
  • The effect was specific to hBD‑2 and required a relatively high sugar concentration

Practical Outcomes

  • HMOs like 3‑FL might be explored as oral‑health supplements to enhance antimicrobial defenses without triggering inflammation, but the study used a tissue model and high concentrations, so real‑world dosing and delivery methods are still unknown. Biohackers should view this as a preliminary hint rather than a ready‑to‑use protocol.

Summary

A lab study using a 3‑D oral tissue model found that two sugars found in human breast milk, especially 3‑fucosyllactose, can boost the natural antimicrobial protein hBD‑2 in gum cells without causing inflammation. The same sugars didn’t change levels of the peptide LL‑37 or inflammatory signals.

Abstract

Human milk oligosaccharides (HMOs), the third largest solid fraction in human milk, can modulate inflammation through Toll-like receptor signaling, but little is known about their immunomodulatory potential in the oral cavity. In this study, we determined whether the HMOs 2'-fucosyllactose (2'-FL) and 3-fucosyllactose (3-FL) regulate human-beta defensin (hBD)-2 and -3, cathelicidin (hCAP18/LL-37), and cytokine responses in human gingival cells using a three-dimensional oral mucosal culture model. The model was incubated with 0.1% or 1% 2'-FL and 3-FL, alone and in combination, for 5 or 24 h, and hBD-2, hBD-3, and hCAP18/LL-37 were analyzed by immunohistochemistry. The expression profiles of interleukin (IL)-1, IL-1RA, IL-8, and monocyte chemoattractant protein (MCP)-1 were determined by LUMINEX immunoassay. The combination of 1% 2'-FL and 1% 3-FL, and 1% 3-FL alone, for 24 h upregulated hBD-2 protein expression significantly (<i>p</i> &lt; 0.001 and <i>p</i> = 0.016, respectively). No changes in the other antimicrobial peptides or proinflammatory cytokines were observed. Thus, 3-FL, alone and in combination with 2'-FL, stimulates oral mucosal secretion of hBD-2, without effecting a proinflammatory response when studied in an oral mucosal culture model.

Study Information

Provider

pubmed

Year

2021

Date

2021-06-11T00:00:00.000Z

DOI

10.3390/pathogens10060739

Citations

10

References

28